Pedro Iturralde
Research Subjects
Pedro Iturralde has a total of 179 co-authors. Here are the top co-authors by number of shared publications:
- Manlio Fabio Márquez
Department of Electrocardiology, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico
11 shared publications - Santiago Nava
Departamento de Electrofisiología, Instituto Nacional de Cardiología Ignacio Chávez, Ciudad de México, Mexico
8 shared publications - Alfredo de Micheli
Instituto Nacional de Cardiologia Ignacio Châvez, México, D.F., México
4 shared publications Argelia Medeiros
Mayo Clinic, Rochester, MN, USA
3 shared publications- Gerardo Rodríguez-Diez
Departamento de Electrofisiología, Centro Médico Nacional 20 de noviembre – ISSSTE, Ciudad de México, México
3 shared publications Gustavo A Medrano
3 shared publications
Latest Publications
- Open Access
- 19 March 2026
- Published by Springer Nature in Journal of Interventional Cardiac Electrophysiology
- Vol. 69 (7) , 1835
Correction: Ablation of manifest accessory pathways in pediatric patients: comparison between conventional and non‑radiological navigation techniques
- 19 March 2026
- Published by Springer Nature in Journal of Interventional Cardiac Electrophysiology
- Vol. 69 (7) , 1835
Open AccessCorrection: Ablation of manifest accessory pathways in pediatric patients: comparison between conventional and non‑radiological navigation techniques
- 17 February 2026
- Published by Springer Nature in Journal of Interventional Cardiac Electrophysiology
- Vol. 69 (7) , 1829-1834
Ablation of manifest accessory pathways in pediatric patients: comparison between conventional and non‑radiological navigation techniques
The purpose was to evaluate clinical characteristics and outcomes of patients under 18 years of age submitted for an electrophysiological study (EPS) for the presence of a manifest accessory pathway (AP) and to compare conventional versus non‑radiological navigation system (NRNS) technics. An observational, multicenter and analytical study was conducted using Latin American Heart Rhythm Society´s pediatric registry. A total of 746 patients underwent EPS due to manifest AP and were all included. The mean age was 10,5 ± 4,4 years, and 471 (63.1%) were male. There were 68 (9,1%) with a structural heart disease and Ebstein’s anomaly was the most frequent congenital heart disease (CHD). Ablation was attempted in 734 (98.4%) and was successful in 694 (94.6%). A NRNS was used in 218 (28.8%) procedures and radiofrequency was used in 728 (97.6%). There were 22 (2.9%) complications, including complete AV block requiring pacemaker implantation in 2 (0.3%) cases. No deaths were reported. After at least one-year follow-up there were 64 (2.2%) patients with manifest AP recurrence. Patients in NRNS group were older (11,6 ± 3,7 vs., 9,6 ± 4,7 years, p < 0,001), had more CHD (13,5% vs. 6,2%, p = 0,004), required less fluoroscopy (6,9 ± 5,9 vs. 20,2 ± 16,5 min, p < 0,001) and achieved higher acute success (99,1% vs. 92,7%, p < 0,001). There were no differences in complications or recurrences. In the multivariate analysis, only the use of NRNS was independently associated with greater effectiveness (p = 0.019). This study reports clinical characteristics, EPS and ablation in children with manifest AP. Ablation using a NRNS was more effective and required less fluoroscopy, without compromising safety. Capsule Summary: In 746 children undergoing EPS for manifest accessory pathways, ablation showed high effectiveness and low complication rates. Non-radiological navigation systems (NRNS) achieved higher acute success and markedly reduced fluoroscopy without compromising safety. Multivariate analysis identified NRNS as an independent predictor of greater effectiveness. Graphical Abstract
- 17 February 2026
- Published by Springer Nature in Journal of Interventional Cardiac Electrophysiology
- Vol. 69 (7) , 1829-1834
Ablation of manifest accessory pathways in pediatric patients: comparison between conventional and non‑radiological navigation techniques
The purpose was to evaluate clinical characteristics and outcomes of patients under 18 years of age submitted for an electrophysiological study (EPS) for the presence of a manifest accessory pathway (AP) and to compare conventional versus non‑radiological navigation system (NRNS) technics. An observational, multicenter and analytical study was conducted using Latin American Heart Rhythm Society´s pediatric registry. A total of 746 patients underwent EPS due to manifest AP and were all included. The mean age was 10,5 ± 4,4 years, and 471 (63.1%) were male. There were 68 (9,1%) with a structural heart disease and Ebstein’s anomaly was the most frequent congenital heart disease (CHD). Ablation was attempted in 734 (98.4%) and was successful in 694 (94.6%). A NRNS was used in 218 (28.8%) procedures and radiofrequency was used in 728 (97.6%). There were 22 (2.9%) complications, including complete AV block requiring pacemaker implantation in 2 (0.3%) cases. No deaths were reported. After at least one-year follow-up there were 64 (2.2%) patients with manifest AP recurrence. Patients in NRNS group were older (11,6 ± 3,7 vs., 9,6 ± 4,7 years, p < 0,001), had more CHD (13,5% vs. 6,2%, p = 0,004), required less fluoroscopy (6,9 ± 5,9 vs. 20,2 ± 16,5 min, p < 0,001) and achieved higher acute success (99,1% vs. 92,7%, p < 0,001). There were no differences in complications or recurrences. In the multivariate analysis, only the use of NRNS was independently associated with greater effectiveness (p = 0.019). This study reports clinical characteristics, EPS and ablation in children with manifest AP. Ablation using a NRNS was more effective and required less fluoroscopy, without compromising safety. Capsule Summary: In 746 children undergoing EPS for manifest accessory pathways, ablation showed high effectiveness and low complication rates. Non-radiological navigation systems (NRNS) achieved higher acute success and markedly reduced fluoroscopy without compromising safety. Multivariate analysis identified NRNS as an independent predictor of greater effectiveness. Graphical Abstract
- 23 June 2025
- Published by Elsevier in Journal of Electrocardiology
- Vol. 92, 154057
First electrocardiographic documentation of alternating bilateral block in pulmonary embolism
- 23 June 2025
- Published by Elsevier in Journal of Electrocardiology
- Vol. 92, 154057
First electrocardiographic documentation of alternating bilateral block in pulmonary embolism
- Open Access
- 20 March 2024
- Published by Elsevier in Heart Rhythm O2
- Vol. 5 (3) , 146-149
Mexican contributions to the electrophysiology field
- 20 March 2024
- Published by Elsevier in Heart Rhythm O2
- Vol. 5 (3) , 146-149
Open AccessMexican contributions to the electrophysiology field
- Open Access
- 12 January 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (2) , 953
KCNQ1 p.D446E Variant as a Risk Allele for Arrhythmogenic Phenotypes: Electrophysiological Characterization Reveals a Complex Phenotype Affecting the Slow Delayed Rectifier Potassium Current (IKs) Voltage Dependence by Causing a Hyperpolarizing Shift and a Lack of Response to Protein Kinase A Activation
Genetic testing is crucial in inherited arrhythmogenic channelopathies; however, the clinical interpretation of genetic variants remains challenging. Incomplete penetrance, oligogenic, polygenic or multifactorial forms of channelopathies further complicate variant interpretation. We identified the KCNQ1/p.D446E variant in 2/63 patients with long QT syndrome, 30-fold more frequent than in public databases. We thus characterized the biophysical phenotypes of wildtype and mutant IKs co-expressing these alleles with the β-subunit minK in HEK293 cells. KCNQ1 p.446E homozygosity significantly shifted IKs voltage dependence to hyperpolarizing potentials in basal conditions (gain of function) but failed to shift voltage dependence to hyperpolarizing potentials (loss of function) in the presence of 8Br-cAMP, a protein kinase A activator. Basal IKs activation kinetics did not differ among genotypes, but in response to 8Br-cAMP, IKs 446 E/E (homozygous) activation kinetics were slower at the most positive potentials. Protein modeling predicted a slower transition of the 446E Kv7.1 tetrameric channel to the stabilized open state. In conclusion, biophysical and modelling evidence shows that the KCNQ1 p.D446E variant has complex functional consequences including both gain and loss of function, suggesting a contribution to the pathogenesis of arrhythmogenic phenotypes as a functional risk allele.
- 12 January 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (2) , 953
Open AccessKCNQ1 p.D446E Variant as a Risk Allele for Arrhythmogenic Phenotypes: Electrophysiological Characterization Reveals a Complex Phenotype Affecting the Slow Delayed Rectifier Potassium Current (IKs) Voltage Dependence by Causing a Hyperpolarizing Shift and a Lack of Response to Protein Kinase A Activation
Genetic testing is crucial in inherited arrhythmogenic channelopathies; however, the clinical interpretation of genetic variants remains challenging. Incomplete penetrance, oligogenic, polygenic or multifactorial forms of channelopathies further complicate variant interpretation. We identified the KCNQ1/p.D446E variant in 2/63 patients with long QT syndrome, 30-fold more frequent than in public databases. We thus characterized the biophysical phenotypes of wildtype and mutant IKs co-expressing these alleles with the β-subunit minK in HEK293 cells. KCNQ1 p.446E homozygosity significantly shifted IKs voltage dependence to hyperpolarizing potentials in basal conditions (gain of function) but failed to shift voltage dependence to hyperpolarizing potentials (loss of function) in the presence of 8Br-cAMP, a protein kinase A activator. Basal IKs activation kinetics did not differ among genotypes, but in response to 8Br-cAMP, IKs 446 E/E (homozygous) activation kinetics were slower at the most positive potentials. Protein modeling predicted a slower transition of the 446E Kv7.1 tetrameric channel to the stabilized open state. In conclusion, biophysical and modelling evidence shows that the KCNQ1 p.D446E variant has complex functional consequences including both gain and loss of function, suggesting a contribution to the pathogenesis of arrhythmogenic phenotypes as a functional risk allele.
- Open Access
- 19 December 2022
- Published by Instituto Nacional Cardovascular - Carlos Alberto Peschiera Carrillo in Archivos Peruanos de Cardiología y Cirugía Cardiovascular
- Vol. 3 (4) , 179-187
Acute and long-term success of ventricular tachycardia ablation in patients with ischemic heart disease in a Mexican center
Objective. To report the results of ventricular tachycardia (VT) catheter ablation in ischemic heart disease (IHD), and to identify risk factors associated with recurrence in a Mexican center. Materials and methods. We made a retrospective review of the cases of VT ablation performed in our center from 2015 to 2022. We analyzed the characteristics of the patients and those of the procedures separately and we determined factors associated with recurrence. Results. Fifty procedures were performed in 38 patients (84% male; mean age 58.1 years). Acute success rate was 82%, with a 28% of recurrences. Female sex (OR 3.33, IC 95% 1.66–6.68, p=0.006), atrial fibrillation (OR 3.5, IC 95% 2.08–5.9, p=0.012), electrical storm (OR 2.4, IC 95% 1.06–5.41, p=0.045), functional class greater than II (OR 2.86, IC 95% 1.34–6.10, p=0.018) were risk factors for recurrence and the presence of clinical VT at the time of ablation (OR0.29, IC95% 0.12–0.70, p=0.004) and the use of more than 2 techniques for mapping (OR 0.64, IC 95% 0.48–0.86, p=0.013) were protective factors. Conclusions. Ablation of ventricular tachycardia in ischemic heart disease has had good results in our center. The recurrence is similar to that reported by other authors and there are some factors associated with it.
- 19 December 2022
- Published by Instituto Nacional Cardovascular - Carlos Alberto Peschiera Carrillo in Archivos Peruanos de Cardiología y Cirugía Cardiovascular
- Vol. 3 (4) , 179-187
Open AccessAcute and long-term success of ventricular tachycardia ablation in patients with ischemic heart disease in a Mexican center
Objective. To report the results of ventricular tachycardia (VT) catheter ablation in ischemic heart disease (IHD), and to identify risk factors associated with recurrence in a Mexican center. Materials and methods. We made a retrospective review of the cases of VT ablation performed in our center from 2015 to 2022. We analyzed the characteristics of the patients and those of the procedures separately and we determined factors associated with recurrence. Results. Fifty procedures were performed in 38 patients (84% male; mean age 58.1 years). Acute success rate was 82%, with a 28% of recurrences. Female sex (OR 3.33, IC 95% 1.66–6.68, p=0.006), atrial fibrillation (OR 3.5, IC 95% 2.08–5.9, p=0.012), electrical storm (OR 2.4, IC 95% 1.06–5.41, p=0.045), functional class greater than II (OR 2.86, IC 95% 1.34–6.10, p=0.018) were risk factors for recurrence and the presence of clinical VT at the time of ablation (OR0.29, IC95% 0.12–0.70, p=0.004) and the use of more than 2 techniques for mapping (OR 0.64, IC 95% 0.48–0.86, p=0.013) were protective factors. Conclusions. Ablation of ventricular tachycardia in ischemic heart disease has had good results in our center. The recurrence is similar to that reported by other authors and there are some factors associated with it.
- Open Access
Tomography and Prognostic Indices in the State of the Art of Evaluation in Hospitalized Patients with COVID-19 Pneumonia
Evaluation in medical emergencies of COVID-19 patients represents a challenge to regulate preventive and timely management. There are key imaging and laboratory tools to classify the severity. The aim of the study was to evaluate the chest CT score performance and prognostic indices in COVID-19 patients to predict the progression to critical illness. This was a retrospective study between run between April and December 2020, in which 109 patients were included. Patients of any age and gender and who required hospitalization due to a confirmed COVID-19 diagnosis by RT-PCR and chest CT and laboratory were analyzed. In 75% of them, there was at least one comorbidity, and 30% developed critical illness, and the average mortality was 10%. In 49.5%, there was a CORADS-5 on admission, and in 50%, there was a peripheral distribution of the interstitial infiltrate in the left lower lobe. The risk factors were FiO2, CT score > 18, and the NRL index. The combination of the high-risk Quick COVID-19 Severity Index (qCSI) plus CT score > 18 indices was the best prediction index for the development of a critical condition. The combined use of indices in infected COVID-19 patients showed diagnostic accuracy and predicted severity. Imaging and the laboratory tests are key tools independent of the wave of recurrence.
Open AccessTomography and Prognostic Indices in the State of the Art of Evaluation in Hospitalized Patients with COVID-19 Pneumonia
Evaluation in medical emergencies of COVID-19 patients represents a challenge to regulate preventive and timely management. There are key imaging and laboratory tools to classify the severity. The aim of the study was to evaluate the chest CT score performance and prognostic indices in COVID-19 patients to predict the progression to critical illness. This was a retrospective study between run between April and December 2020, in which 109 patients were included. Patients of any age and gender and who required hospitalization due to a confirmed COVID-19 diagnosis by RT-PCR and chest CT and laboratory were analyzed. In 75% of them, there was at least one comorbidity, and 30% developed critical illness, and the average mortality was 10%. In 49.5%, there was a CORADS-5 on admission, and in 50%, there was a peripheral distribution of the interstitial infiltrate in the left lower lobe. The risk factors were FiO2, CT score > 18, and the NRL index. The combination of the high-risk Quick COVID-19 Severity Index (qCSI) plus CT score > 18 indices was the best prediction index for the development of a critical condition. The combined use of indices in infected COVID-19 patients showed diagnostic accuracy and predicted severity. Imaging and the laboratory tests are key tools independent of the wave of recurrence.
- Open Access
- 29 September 2022
- Published by Instituto Nacional Cardovascular - Carlos Alberto Peschiera Carrillo in Archivos Peruanos de Cardiología y Cirugía Cardiovascular
- Vol. 3 (3) , 132-138
Relación del intervalo QT corregido con la escala GRACE en pacientes con infarto de miocardio sin elevación del segmento ST
Background. The Global Registry of Acute Coronary Events (GRACE) prediction model stratifies patients with non-ST-segment elevation myocardial infarction (NSTEMI). Corrected QT interval (QTc) is not considered in this model. Objective. To evaluate the relationship between the QTc interval and the GRACE score in patients with NSTEMI. Materials and methods. An observational, retrospective study was carried between 2016 and 2019. We included patients with diagnosis of NSTEMI, QTc intervals were calculated with Bazett’s formula, and they were classified into 2 groups: a normal QTc interval (<440 ms) and prolonged (≥440 ms). According to the GRACE score they were classified in three ranges: low risk (≤109 points), intermedium (110 - 139 points) and high (≥140 points), we determined if there were a correlation between QTc interval and the GRACE score. Results. A total of 940 patients with a diagnosis of NSTEMI were admitted in our institution, 634 met the inclusion criteria, there were 390 patients with normal QTc interval and 244 with a prolonged QTc interval. Patients with prolonged QTc were older (65.5 vs 61, p=0.001) with a lower proportion of males (71.7% vs 82.8%, p=0.001). An association was found between the GRACE score and the QTC interval, subjects with a normal QTc had a greater proportion of low and intermediate risk than those with a prolonged QTc (p=0.001). Conclusions. In NSTEMI patients, a normal QTc interval (<440 ms) is associated with a GRACE risk score of low or intermediate risk.
- 29 September 2022
- Published by Instituto Nacional Cardovascular - Carlos Alberto Peschiera Carrillo in Archivos Peruanos de Cardiología y Cirugía Cardiovascular
- Vol. 3 (3) , 132-138
Open AccessRelación del intervalo QT corregido con la escala GRACE en pacientes con infarto de miocardio sin elevación del segmento ST
Background. The Global Registry of Acute Coronary Events (GRACE) prediction model stratifies patients with non-ST-segment elevation myocardial infarction (NSTEMI). Corrected QT interval (QTc) is not considered in this model. Objective. To evaluate the relationship between the QTc interval and the GRACE score in patients with NSTEMI. Materials and methods. An observational, retrospective study was carried between 2016 and 2019. We included patients with diagnosis of NSTEMI, QTc intervals were calculated with Bazett’s formula, and they were classified into 2 groups: a normal QTc interval (<440 ms) and prolonged (≥440 ms). According to the GRACE score they were classified in three ranges: low risk (≤109 points), intermedium (110 - 139 points) and high (≥140 points), we determined if there were a correlation between QTc interval and the GRACE score. Results. A total of 940 patients with a diagnosis of NSTEMI were admitted in our institution, 634 met the inclusion criteria, there were 390 patients with normal QTc interval and 244 with a prolonged QTc interval. Patients with prolonged QTc were older (65.5 vs 61, p=0.001) with a lower proportion of males (71.7% vs 82.8%, p=0.001). An association was found between the GRACE score and the QTC interval, subjects with a normal QTc had a greater proportion of low and intermediate risk than those with a prolonged QTc (p=0.001). Conclusions. In NSTEMI patients, a normal QTc interval (<440 ms) is associated with a GRACE risk score of low or intermediate risk.
- Open Access
Clinical Spectrum of SCN5A Channelopathy in Children with Primary Electrical Disease and Structurally Normal Hearts
Sodium voltage-gated channel α subunit 5 (SCN5A)-mutations may cause an array of arrhythmogenic syndromes most frequently as an autosomal dominant trait, with incomplete penetrance, variable expressivity and male predominance. In the present study, we retrospectively describe a group of Mexican patients with SCN5A-disease causing variants in whom the onset of symptoms occurred in the pediatric age range. The study included 17 patients with clinical diagnosis of primary electrical disease, at least one SCN5A pathogenic or likely pathogenic mutation and age of onset SCN5A mutation carriers were affected (overall penetrance 53.3%), and penetrance was higher in males (63.3%, 19 affected/30 mutation carriers) than in females (33.3%, 5 affected/15 carriers). In conclusion, pediatric patients with SCNA-disease causing variants presented mainly as overlap syndrome, with predominant loss-of-function phenotypes of sick sinus syndrome (SSS), progressive cardiac conduction disease (PCCD) and ventricular arrhythmias.
Open AccessClinical Spectrum of SCN5A Channelopathy in Children with Primary Electrical Disease and Structurally Normal Hearts
Sodium voltage-gated channel α subunit 5 (SCN5A)-mutations may cause an array of arrhythmogenic syndromes most frequently as an autosomal dominant trait, with incomplete penetrance, variable expressivity and male predominance. In the present study, we retrospectively describe a group of Mexican patients with SCN5A-disease causing variants in whom the onset of symptoms occurred in the pediatric age range. The study included 17 patients with clinical diagnosis of primary electrical disease, at least one SCN5A pathogenic or likely pathogenic mutation and age of onset SCN5A mutation carriers were affected (overall penetrance 53.3%), and penetrance was higher in males (63.3%, 19 affected/30 mutation carriers) than in females (33.3%, 5 affected/15 carriers). In conclusion, pediatric patients with SCNA-disease causing variants presented mainly as overlap syndrome, with predominant loss-of-function phenotypes of sick sinus syndrome (SSS), progressive cardiac conduction disease (PCCD) and ventricular arrhythmias.
- 1 February 2021
- Published by Elsevier in Archives of Medical Research
- Vol. 52 (2) , 233-239
Obesity Paradox and 12 Month Outcome in Patients with Atrial Fibrillation
- 1 February 2021
- Published by Elsevier in Archives of Medical Research
- Vol. 52 (2) , 233-239
Obesity Paradox and 12 Month Outcome in Patients with Atrial Fibrillation